PedAM
Pediatric Disease Annotations & Medicines
| Disease | neutropenia |
| Phenotype | C0242379|lung cancer |
| Sentences | 8 |
| PubMedID- 23053498 | In the present study, we searched for predictive factors for the failure of the initial antimicrobial agents used for febrile neutropenia (fn) in patients with lung cancer. |
| PubMedID- 23173291 | [febrile neutropenia in lung cancer patients]. |
| PubMedID- 21707992 | In view of the scarcity of data on lung cancer patients with febrile neutropenia, we performed a retrospective study of the microbiological characteristics of cases recorded in three medical centers in the picardy region of northern france. |
| PubMedID- 24679653 | Cefepime 1 g intravenously every 8 h appears to be effective for febrile neutropenia in patients with lung cancer, especially in those with low-risk febrile neutropenia, and is well tolerated. |
| PubMedID- 22133387 | The highest incidence of severe neutropenia was found in patients with non-small cell lung cancer (61%; 95% ci 50, 74), while the lowest incidence was seen in patients with squamous cell carcinoma of the esophagus (22%; 95% ci 11, 45). |
| PubMedID- 21773751 | Identifying risk factors for refractory febrile neutropenia in patients with lung cancer. |
| PubMedID- 23489558 | Clinicians should be aware that gefitinib-induced neutropenia in patients with non-small cell lung cancer can be treated successful by switching to erlotinib. |
| PubMedID- 26434104 | Pentraxin-3 as a biomarker for febrile neutropenia in patients with lung cancer. |
Page: 1